|
| Status |
Public on Apr 18, 2019 |
| Title |
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
bulk RNAseq of MUC1 kidney disease patient derived kidney epithelial cells compare to normal kidney cells. The goal of this study was to elucidate the biological mechanism underlying MUC1 kidney disease using MUC1 expressing cells derived from either a patient or a healthy individual kidney
|
| |
|
| Overall design |
Bulk RNAseq of immortalized patient compare to normal cell line
|
| |
|
| Contributor(s) |
Levitt MD, Kohnert E |
| Citation(s) |
31348885 |
| |
| Submission date |
Apr 17, 2019 |
| Last update date |
Aug 28, 2019 |
| Contact name |
Moran Dvela Levitt |
| E-mail(s) |
dvelamo@broadinstitute.org
|
| Organization name |
Broad Institute
|
| Lab |
Greka Lab
|
| Street address |
415 Main Street
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02142 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (6)
|
|
| This SubSeries is part of SuperSeries: |
| GSE129971 |
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy |
|
| Relations |
| BioProject |
PRJNA533239 |
| SRA |
SRP192834 |
Less...
More...